PUBLICATIONS FDA Decisions Expected: May 2025 Your monthly synopsis of new drugs expected to hit the market April 14, 2025 Drug pipeline for May 2025 At Prime Therapeutics (Prime), we have...

Event features discussions about health care industry trends, best practices and innovations

publications High-Cost Therapy Profile: April 2025 Deramiocel Intravenous (IV) | Nippon Shinyaku Co., Ltd./Capricor Therapeutics, Inc. Cardiovascular/Musculoskeletal April 15, 2025 Proposed...

Special Investigations Unit helps promote safety to prevent fraud, waste and abuse schemes

publications Drug Approvals: January 2025 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches January 31, 2025 Specialty New drugs Dec....

publications Drug Approvals: December 2024 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches December 30, 2024 Specialty New drugs...

Drug Approvals Quarterly Update: January 2024 This wrap-up provides a review of newly approved drugs, recent drug launches, new indications and news of note on drugs in the approval process....

Stories, perspectives and news coverage of Prime Therapeutics/Magellan Rx from AMCP 2024

In this episode, our experts discuss Prime’s four primary tenets of practice for chronic weight management.

Cover image for Drug Approvals Monthly Update: September 2024 This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a review of newly approved specialty...